Home / News
-
-
April 25, Swiss drugmaker Roche's (ROG.S) first quarter sales rose a better-than-expected 10% on strong U.S. demand for rapid COVID-19 antigen tests and drugs including Ocrevus against multiple sclerosis as well as Hemlibra against haemophilia.2022-04-25View More
-
-
For the three months ending March 31, total revenue was 74,283.49 million CNY compared to 39.53% growth in the year-ago period with the total profit of 35, 813.66 million CNY compared to 76.23% growth over the same period last year.2022-04-22View More
-
-
Existing methods for detecting and diagnosing COVID-19 are either expensive and complex or inaccurate.2022-04-22View More
-
-
Danaher reported on Thursday a 12 percent year-over-year increase in total revenues.2022-04-22View More
-
-
On April 19, Maccura Biotechnology Co., Ltd. released its 2021 annual financial report. The company achieved CNY 3.981 billion revenue in 2021, a year-on-year increase of 7.47%; net profit attributable to shareholders of listed companies was CNY 957 million, a year-on-year increase of 20.49%.2022-04-21View More
-
-
Abbott announced before the market opened on Wednesday that its first quarter Diagnostics business revenues grew 32 percent year over year.2022-04-21View More
-
-
With the help of single-cell sequencing, a team from Boston Children's Hospital, the Broad Institute, Harvard Medical School, and elsewhere has found evidence for enhanced somatic mutation in brain cells from individuals with Alzheimer's disease.2022-04-21View More
-
-
A point-of-care COVID-19 test developed by researchers at the University of Illinois Urbana-Champaign can now detect and differentiate the alpha variant of the SARS-CoV-2 virus from earlier strains in saliva samples.2022-04-20View More
-
-
Diagnostics instrument and reagent developer MicroGem announced on Tuesday that it has obtained Emergency Use Authorization from the US Food and Drug Administration for a rapid point-of-care PCR instrument and COVID test.2022-04-20View More
-
-
On April 19, Mindary (300760.SZ) released its 2021 annual report, showing that in 2021 the company achieved revenue of CNY 25.270 billion, up 20.18%, achieved net profit attributable to the mother company of CNY 8.002 billion, up 20.19%.2022-04-20View More
-
-
In 2021, Gongdong Medical achieved operating income of CNY 1.194 billion, a year-on-year increase of 43.95%; net profit attributable to the parent company of CNY 311 million, a year-on-year increase of 37.68%.2022-04-19View More
-
-
Thermo Fisher Scientific has launched its first GMP-manufactured Cas9 protein for clinical genome editing research.2022-04-19View More
-
-
Chinese diagnostics firm Amoy Diagnostics on Monday announced that it has entered into a collaboration agreement with AstraZeneca to develop and commercialize AmoyDx assays that may cover any type of indication or biomarker for companion diagnostic use with AstraZeneca medicines.2022-04-19View More
-
-
On April 15, Wuhan Easy Diagnosis Biomedicine, Shenzhen YHLO Biotech and Acrobiosystemsreleased its first quarter results forecast for 20222022-04-18View More
-
-
Eurobio Scientific said on Thursday that its molecular SARS-CoV-2 test for detecting viral variants has received CE marking.2022-04-18View More
-
-
The US Food and Drug Administration this week granted Emergency Use Authorization for the Cleveland Clinic's SelfCheck Cobas SARS-CoV-2 + Flu Assay.2022-04-18View More
-
-
Shanghai Rigen Biotech Co., Ltd. (hereinafter referred to as "Rigen") recently completed a new round of financing of nearly 100 million CNY.2022-04-15View More
-
-
The US Food and Drug Administration on Thursday announced it has granted Emergency Use Authorization to InspectIR Systems' InspectIR COVID-19 Breathalyzer test, making it the first breath-based test for detecting SARS-CoV-2 to receive such designation.2022-04-15View More
-
-
Shanghai Fosun Pharmaceutical on Thursday announced that China's National Medical Products Administration (NMPA) has granted approval for Fosun Diagnostic's Novel Coronavirus (2019-nCoV) Antigen Detection Kit (Colloidal Gold) for COVID-19 screening.2022-04-15View More
-
-
On April 13, the SARS-CoV-2 Rapid Antigen Test (immunochromatography Assay) developed by Sansure Biotech Inc. has obtained CE certification! This means that the test can be sold in EU countries and countries that recognize EU CE certification.2022-04-14View More
- CAIVD WeChat
Subscription Account
- CAIVD WeChat
Channels
China Association of In-vitro Diagnostics
Part of the information in our website is from the internet.
If by any chance it violates your rights, please contact us.